It’s Budget Time! Thoughts On Providing a Robust eJournal Collection

Posted on by

As I prepare my budget for 2018, the challenge is always to align the collections we maintain and determine that new content purchased, reflects the research and medical activities of our user community, and supports the mission of the Center. Scholarly journals tend to take a fair portion of our allocated content funds and considerable time is spent each year (and during the year) monitoring their use, identifying new research journals, and looking to see where research dollars have been assigned/diverted within the organization. Continue reading →

The Journal of Patient Experience from @SAGE_News is #OpenAccess and New to the Library

Posted on by

The library has recently added the Journal of Patient Experience (JPE), an open-access, peer-reviewed journal published by the Association for Patient Experience.  JPE accepts a variety of submissions such as original research articles, case reports, commentaries, patient narratives, and cover art centered around advances and applications that impact the patient experience. Topics should address JPE’s broad and interdisciplinary readership which includes clinical practitioners, patients and caregivers, healthcare executives and professional societies.  Authors interested in submitting to the journal should consult the submission guidelines.

The Journal of Patient Experience may be accessed through our eJournal A-Z listing.

Young Patient Thanks “Heroes” at MSK

Posted on by

11-year-old Jonathan Varghese is on his way to being just a normal healthy kid thanks to his “heroes” at MSK. After a routine tonsillectomy in August 2015, his doctors, concerned that there was something more going on, sent his tissues for screening. It was then that they learned he had Acute Lymphoblastic Leukemia (ALL). With a recommendation from an oncologist friend in Boston, Jonathan began a two-year intensive chemotherapy protocol developed at MSK under the supervision of Dr. Peter Steinherz. With this therapy, there was a 90% success rate for patients treated at the hospital. Jonathan only has a few months left of his protocol. “His prognosis is excellent,” Steinherz said. “The first year is the riskiest. Over the next two years, he has about a 10% risk of something coming back.”